Xinghu Technology disclosed its earnings forecast, expecting attributable net profit for the first half of 2026 to be between 60 million and 85 million yuan, a year-on-year decline of 89.84% to 92.83%. Deducted non-recurring net profit is expected to be between 43 million and 60 million yuan, a year-on-year decline of 92.55% to 94.66%. The company primarily focuses on the research, development, production, and sales of food additives, feed additives, and pharmaceutical intermediates and active pharmaceutical ingredients. The change in performance is mainly affected by market supply and demand dynamics, with sales prices of major products declining, leading to reduced product gross margins and an overall year-on-year decline in profit.
Starlake Bioscience Co Inc Zhaoqing GuangdongCompany expects net profit to drop 89-93% due to market supply-demand dynamics and falling sales prices.